Drug Type Small molecule drug |
Synonyms HDT401 |
Target |
Mechanism RIG-I stimulants(Retinoic acid-inducible gene I stimulants), TLR3 agonists(Toll like receptor 3 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization HDT Bio Corp.Startup |
Active Organization HDT Bio Corp.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Head and Neck Neoplasms | Preclinical | US | HDT Bio Corp.Startup | - |